Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease

N. A. Youssef, M. F. Abdelmalek, Martin Binks, C. D. Guy, A. Omenetti, A. D. Smith, A. M. Diehl, A. Suzuki

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Depression and anxiety are common in patients with nonalcoholic fatty liver disease (NAFLD). However, their associations with histological severity of NAFLD are unknown. AIM: This study examined the association(s) of depression, anxiety and antidepressant pharmacotherapy with severity of histological features in patients with NAFLD. METHODS: We analysed 567 patients with biopsy-proven NAFLD enrolled in the Duke NAFLD Clinical Database. Depressive and anxiety symptoms were assessed using the Hospital Anxiety & Depression Scale (HADS). The associations of depression and anxiety with severity of histological features of NAFLD were analysed using multiple logistic (or ordinal logistic) regression models with and without adjusting for confounding factors. RESULT: Subclinical and clinical depression was noted in 53% and 14% of patients respectively. Subclinical and clinical anxiety was noted in 45% and 25% of patients respectively. After adjusting for confounders, depression was
Original languageEnglish
Pages (from-to)1062-70
JournalLiver Int
StatePublished - 2013

Fingerprint Dive into the research topics of 'Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease'. Together they form a unique fingerprint.

  • Cite this

    Youssef, N. A., Abdelmalek, M. F., Binks, M., Guy, C. D., Omenetti, A., Smith, A. D., Diehl, A. M., & Suzuki, A. (2013). Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. Liver Int, 1062-70.